Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PNISR antisense RNA 1 (PNISR-AS1) is a long noncoding RNA transcribed antisense to the *PNISR* gene. Like other antisense lncRNAs, it is presumed to regulate the expression of its sense gene and possibly other loci through mechanisms such as epigenetic modification, recruitment of chromatin modifiers, or direct base pairing with mRNA. Antisense lncRNAs are increasingly recognized for their diverse roles in gene silencing, imprinting, and RNA stability regulation, particularly in cancer and developmental processes. While no PNISR-AS1-specific role has been characterized to date, it may participate in the regulation of gene expression in a manner analogous to other antisense RNAs[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PNISR antisense RNA 1 (PNISR-AS1).